XML 57 R40.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE CAPITAL, WARRANTS AND OPTIONS (Details Narrative)
 1 Months Ended 6 Months Ended
Aug. 31, 2020
CAD ($)
$ / shares
shares
Aug. 13, 2020
CAD ($)
$ / shares
shares
Apr. 20, 2021
CAD ($)
$ / shares
shares
Jun. 30, 2021
CAD ($)
shares
Integer
$ / shares
Jun. 30, 2020
CAD ($)
shares
$ / shares
Mar. 23, 2021
shares
Dec. 31, 2020
shares
IfrsStatementLineItems [Line Items]              
Expected dividend yield       0.00% 0.00%    
Risk-free interest rate       0.93% 1.21%    
Expected volatility       127.83% 121.55%    
Share capital issued through exercise of warrants | $       $ 670,000      
Common stock, share issued | shares           251,000  
Expense from share-based payment transactions on grant of options | $       837,444 $ 884,247    
Transfer to deficit for expired options and warrants | $       97,953 199,971    
Transfer to common share capital for expired warrants | $       $ 244,357    
Stock Option Plan [Member]              
IfrsStatementLineItems [Line Items]              
Period of options granted       5 years 5 years    
Number of stock option granted | shares       3,185,000 6,650,000    
Stock options exercisable price per share | $ / shares       $ 0.32 $ 0.16    
Top of range [member]              
IfrsStatementLineItems [Line Items]              
Number of votes per share at meeting of holders of preference shares | Integer       1      
Period from date of issuance when shares become convertible       6 months      
Period of notice to convert shares       10 days      
Percentage of beneficially owns, issued and outstanding       10.00%      
Period of options granted       10 years      
Non Brokered Private Placement [Member]              
IfrsStatementLineItems [Line Items]              
Number of units issued | shares     8,290,665        
Price of unit issued | $ / shares     $ 0.24        
Total gross proceeds | $     $ 1,989,760        
Warrant description Each warrant will entitle the holder to acquire one common share of the Company at an exercise price of $0.09 for a period of 24 months from its date of issuance. The warrants are subject to an acceleration clause such that if the closing market price of the common shares on the TSX-V is greater than $0.12 per common share for a period of 10 consecutive trading days at any time after the four-month anniversary of the closing of the placement, the Company may, at its option, accelerate the warrant expiry date to within 30 days.   Each full Warrant entitles the holder to acquire one common share of the Company within twenty-four (24) months following its issuance date, at a price of $0.35. The warrants are subject to an acceleration clause such that if the closing market price of the common shares on the TSX-V is greater than $0.60 per common share for a period of 10 consecutive trading days at any time after the four-month anniversary of the closing of the placement, the Company may, at its option, accelerate the warrant expiry date to within 30 days.        
Share issuance costs in cash | $ $ 124,222   $ 57,190        
Finder's fee paid in common share purchase warrant | shares 588,154   238,289        
Exercise price of warrant | $ / shares $ 0.09   $ 0.35        
Fair value of warrants issued | $ $ 716,055   $ 580,187        
Expected life 2 years   2 years        
Expected dividend yield 0.00%   0.00%        
Risk-free interest rate     0.29%        
Expected volatility     163.00%        
Non Brokered Private Placement [Member] | Top of range [member]              
IfrsStatementLineItems [Line Items]              
Risk-free interest rate 0.28%            
Expected volatility 158.00%            
Non Brokered Private Placement [Member] | Bottom of range [member]              
IfrsStatementLineItems [Line Items]              
Risk-free interest rate 0.31%            
Expected volatility 158.53%            
Non Brokered Private Placement [Member] | First Tranche [Member]              
IfrsStatementLineItems [Line Items]              
Number of units issued | shares   15,481,077          
Price of unit issued | $ / shares   $ 0.07          
Total gross proceeds | $   $ 1,083,675          
Non Brokered Private Placement [Member] | Second And Final Tranche [Member]              
IfrsStatementLineItems [Line Items]              
Number of units issued | shares 5,661,780            
Price of unit issued | $ / shares $ 0.07            
Total gross proceeds | $ $ 396,325            
Non Brokered Private Placement [Member] | Agent S Warrants [Member]              
IfrsStatementLineItems [Line Items]              
Fair value of warrants issued | $ $ 18,547   $ 33,351        
Series 1 Convertible Preferred Shares [Member]              
IfrsStatementLineItems [Line Items]              
Authorized capital | shares       100,000,000      
Ordinary shares [member]              
IfrsStatementLineItems [Line Items]              
Share capital issued through exercise of warrants, shares | shares       6,325,019      
Share capital issued through exercise of warrants | $       $ 669,547      
Common stock, share issued | shares       124,449,332 88,690,791   109,833,648
Shares outstanding | shares       124,449,332 88,690,791   109,833,648
Series 1 Preferred Shares [Member]              
IfrsStatementLineItems [Line Items]              
Shares outstanding | shares       590,931 590,931    
Preference shares [member]              
IfrsStatementLineItems [Line Items]              
Conversion value of share | $ / shares       $ 1      
Factor by which number of shares on conversion is calculated | $ / shares       $ 9.00